Elective DC cardioversion: a comparison of the carbon footprint of the care pathways for warfarin and DOAC treated patients
- PMID: 34286211
- PMCID: PMC8285148
- DOI: 10.7861/fhj.Let.8.2.2
Elective DC cardioversion: a comparison of the carbon footprint of the care pathways for warfarin and DOAC treated patients
Figures
References
-
- NHS . Care pathways: Guidance on appraising sustainability. NHS, 2015. %%%www.sduhealth.org.uk/documents/publications/2015/CSPM%20Care%20Pathways%...
-
- NHS . Identifying high greenhouse gas intensity prescription items. NHS, 2014. www.sduhealth.org.uk/documents/publications/2014/GHG_Prescription_Feb_20... [Accessed 19 November 2020].
-
- Parvatker A, Tunceroglu H, Sherman JD, et al. . Cradle-to-gate greenhouse gas emissions for twenty anaesthetic active pharmaceutical ingredients based on process scale-up and process design calculations. ACS Sustainable Chem Eng 2019;7:6580–91.
-
- Bhonoah Y. Synthesis. www.ch.ic.ac.uk/local/projects/bhonoah/synthesis.html (Accessed 20/01/21).
-
- Mali AC, Deshmukh DG, Joshi DR, et al. . Facile approach for the synthesis of rivaroxaban using alternate synthon: reaction, crystallization and isolation in single pot to achieve desired yield, quality and crystal form. Sustain Chem Process 2015;3:11.
LinkOut - more resources
Full Text Sources